ARPA-H’s Genetic Medicines and Individualized Manufacturing for Everyone (GIVE) program seeks to develop a distributed network for manufacturing and quality-control testing of RNA-based genetic medicines. Its two focus areas are automated RNA manufacturing and integrated quality control. The program aims to support production across multiple sites, products, and scales, bringing manufacturing closer to patients. In September 2026, ARPA-H announced five funded teams developing manufacturing and quality-control platforms, including systems for DNA/RNA production, fill-finish, and testing.